20-F XBRL

FORM 20-F

Company: Galmed Pharmaceuticals Ltd.
Filed: March 12, 2020
Period of Report: December 31, 2019
Accession Number: 0001104659-20-032166

View Document ↗ View on SEC.gov ↗